Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.

Saved in:
Bibliographic Details
Title: Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.
Authors: Ughi N; Multispecialist Medical Department, Division of Rheumatology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. nicola.ughi@ospedaleniguarda.it., Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Dec; Vol. 25 (24), pp. 7985-7996.
Publication Type: Journal Article
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34982462
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ughi+N%22">Ughi N</searchLink>; Multispecialist Medical Department, Division of Rheumatology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. nicola.ughi@ospedaleniguarda.it.<br /><searchLink fieldCode="AU" term="%22Del+Gaudio+F%22">Del Gaudio F</searchLink><br /><searchLink fieldCode="AU" term="%22Dicuonzo+A%22">Dicuonzo A</searchLink><br /><searchLink fieldCode="AU" term="%22Orso+M%22">Orso M</searchLink><br /><searchLink fieldCode="AU" term="%22Micheloni+G%22">Micheloni G</searchLink><br /><searchLink fieldCode="AU" term="%22Puoti+M%22">Puoti M</searchLink><br /><searchLink fieldCode="AU" term="%22Pani+A%22">Pani A</searchLink><br /><searchLink fieldCode="AU" term="%22Scaglione+F%22">Scaglione F</searchLink><br /><searchLink fieldCode="AU" term="%22Zoppini+L%22">Zoppini L</searchLink><br /><searchLink fieldCode="AU" term="%22Rossetti+C%22">Rossetti C</searchLink><br /><searchLink fieldCode="AU" term="%22Epis+OM%22">Epis OM</searchLink><br /><searchLink fieldCode="AU" term="%22Bellavia+G%22">Bellavia G</searchLink><br /><searchLink fieldCode="AU" term="%22Giroldi+S%22">Giroldi S</searchLink><br /><searchLink fieldCode="AU" term="%22Moreno+M%22">Moreno M</searchLink><br /><searchLink fieldCode="AU" term="%22Bosio+M%22">Bosio M</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229717360%22">European review for medical and pharmacological sciences</searchLink> [Eur Rev Med Pharmacol Sci] 2021 Dec; Vol. 25 (24), pp. 7985-7996.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Verduci%22">Verduci </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>9717360 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2284-0729 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211283602%22">11283602 </searchLink><i>NLM ISO Abbreviation: </i>Eur Rev Med Pharmacol Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34982462
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.26355/eurrev_202112_27649
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7985
    Titles:
      – TitleFull: Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ughi N
      – PersonEntity:
          Name:
            NameFull: Del Gaudio F
      – PersonEntity:
          Name:
            NameFull: Dicuonzo A
      – PersonEntity:
          Name:
            NameFull: Orso M
      – PersonEntity:
          Name:
            NameFull: Micheloni G
      – PersonEntity:
          Name:
            NameFull: Puoti M
      – PersonEntity:
          Name:
            NameFull: Pani A
      – PersonEntity:
          Name:
            NameFull: Scaglione F
      – PersonEntity:
          Name:
            NameFull: Zoppini L
      – PersonEntity:
          Name:
            NameFull: Rossetti C
      – PersonEntity:
          Name:
            NameFull: Epis OM
      – PersonEntity:
          Name:
            NameFull: Bellavia G
      – PersonEntity:
          Name:
            NameFull: Giroldi S
      – PersonEntity:
          Name:
            NameFull: Moreno M
      – PersonEntity:
          Name:
            NameFull: Bosio M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2021 Dec
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2284-0729
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: European review for medical and pharmacological sciences
              Type: main
ResultId 1